Tue. Feb 24th, 2026

AstraZeneca gets regulator’s nod to market cancer drug in India

ByBengal Watch Web Desk

Oct 7, 2025

Spread the love

Trastuzumab Deruxtecan is already approved in India for the treatment of metastatic breast cancer and locally advanced or metastatic gastric cancer

Trastuzumab Deruxtecan is already approved in India for the treatment of metastatic breast cancer and locally advanced or metastatic gastric cancer

Post Views: 8

By Bengal Watch Web Desk

Related Post

PM Modi’s Israel visit triggers political tussle: Opposition threatens to boycott Parliamenton February 24, 2026 at 1:37 am

Feb 24, 2026 Bengal Watch Web Desk

Bihar to explore potential of cooperative farming, teams to visit Gujarat

Feb 24, 2026 Bengal Watch Web Desk

What is Israel’s ‘Hexagon of Alliance’? Is Netanyahu trying to corner India?on February 24, 2026 at 12:18 am

Feb 24, 2026 Bengal Watch Web Desk

You missed

PM Modi’s Israel visit triggers political tussle: Opposition threatens to boycott Parliamenton February 24, 2026 at 1:37 am

February 24, 2026 Bengal Watch Web Desk

Bihar to explore potential of cooperative farming, teams to visit Gujarat

February 24, 2026 Bengal Watch Web Desk

What is Israel’s ‘Hexagon of Alliance’? Is Netanyahu trying to corner India?on February 24, 2026 at 12:18 am

February 24, 2026 Bengal Watch Web Desk

India, Russia fuel oil battle: West Asia crude imports soar like never before – here’s whyon February 23, 2026 at 11:57 pm

February 24, 2026 Bengal Watch Web Desk